|
D. C. Hutfield: History of herpes genitalis. Br. J. Vener. Dis. (1966) 42(4): S. 263-268 PMID 5333786 (pdf)
R. Marre, T. Mertens, M. Trautmann, E. Vanek: Klinische Infektiologie. München Jena 2000 ISBN 3-437-21740-2 S. 578ff, 596ff, 189f
H. Hahn, D. Falke, S. H. E. Kaufmann, U. Ullmann: Medizinische Mikrobiologie und Infektiologie. 5. Aufl., Heidelberg 2005 ISBN 3-540-21971-4, S. 610ff
C. Mims, H. M. Dockrell et al.: Medizinische Mikrobiologie / Infektiologie. München (Elsevier) 2006 ISBN 3-437-41272-8
R. H. Kampmeier: Herpes genitalis: a clinical puzzle for two centuries. Sex. Trans. Dis. (1984) 11: S. 41
Mercutio zu Romeo im 1. Akt, 4. Szene (Text auf Wikisource)
Jean Astruc: De morbis venereis. Paris 1736 und A Treatise of Venereal Diseases. London 1754, Band 1, 3. Buch, S. 365
P. G. Unna, J. cutan. vener. Dis. (1883) 1: S. 321, zugänglich in: J. K. Oates: Venereal disease genital herpes. J. Hosp. Med. (1983) 6: S. 13-19
H. B. Slavin, E. Gavett: Primary herpetic vulvovaginitis. Proc. Soc. Exp. Biol. Med. (1946) 63: S. 343
L. L. Coriell, G. Rake et al.: Electron microscopy of herpes simplex. J. Bacteriol. (1950) 59(1): S. 61–68 PMID 15400321
Karl Eduard Schneweis: Untersuchungen zur antigenen Analyse und zur Typendifferenzierung beim Herpesvirus hominis. Göttingen 1962
K. E. Schneweis, A. J. Nahmias: Antigens of Herpes simplex virus type 1 and 2-immunodiffusion and inhibition passive hemagglutination studies. Z. Immunitätsforsch. Exp. Klin. Immunol. (1971) 141(5): S. 471-487 PMID 4326538
J. F. Szilágyi, J. Berriman: Herpes simplex virus L particles contain spherical membrane-enclosed inclusion vesicles. J. Gen. Virol. (1994) 75 (7): S. 1749–1753 PMID 8021604
W. Hellenbrand, W. Thierfelder et al.: Seroprevalence of herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in former East and West Germany, 1997–1998. Eur. J. Clin. Microbiol. Infect. Dis. (2005) 24(2): S. 131-135 PMID 15692814
Eine Übersicht verschiedener epidemiologischer Studien in B. Halioua, J. E. Malkin: Epidemiology of genital herpes - recent advances. Eur J Dermatology (1999) 9(3): S. 177-184. PMID 10210781 (Tabelle 2)
C. A. Daniels, S. G. LeGoff: Shedding of infectious virus/antibody complexes from vesicular lesions of patients with recurrent herpes labialis. Lancet (1975) 20;2(7934): S. 524-528 PMID 51344
W. W. Liu, J. Goodhouse, N. L. Jeon, L. W. Enquist: A microfluidic chamber for analysis of neuron-to-cell spread and axonal transport of an alpha-herpesvirus. PLoS ONE (2008) 18;3(6):e2382 PMID 18560518 Volltext
D. Malvy et al.: Epidemiology of orofacial herpes simplex virus infections in the general population in France: results of the HERPIMAX study. J. Eur. Acad. Dermatol. Venereol. (2007) 21(10): S. 1398–1403 PMID 17958848
B. Selling, S. Kibrick: An outbreak of Herpes simplex among wrestlers (Herpes gladiatorum). New England J. Med. (1964) 7;270: S. 979-982 PMID 14122793
B. J. Anderson: The epidemiology and clinical analysis of several outbreaks of herpes gladiatorum. Med. Sci. Sports Exerc. (2003) 35(11): S. 1809–1814 PMID 14600542
W. B. White, J. M. Grant-Kels: Transmission of herpes simplex virus type 1 infection in rugby players. JAMA (1984) 27;252(4): S. 533-535 PMID 6737650
I. R. Sanderson et al.: Eczema herpeticum: a potentially fatal disease. Br. Med. J. (1987) 294(6573): S. 693-694 PMID 3105692 pdf
Übersicht in: M. Cordero-Coma et al.: Herpetic retinitis. Herpes (2007) 14(1): S. 4-10 (Review) PMID 17848212
J. Maertzdorf et al.: Herpes simplex virus type 1 (HSV-1)-induced retinitis following herpes simplex encephalitis: indications for brain-to-eye transmission of HSV-1. Ann. Neurol. (2001) 49(1): S. 104-106 PMID 11198277
A. Klein, P. Lefebvre: Three consecutive episodes of acute retinal necrosis due to herpes simplex-1 over twelve years following herpetic encephalitis. Ocul. Immunol. Inflamm. (2007) 15(5): S. 411-413 (Review) PMID 17972228
S. Murakami et al.: Bell’s palsy and herpes simplex virus: Identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med (1996) 124 (1): S. 27–30 PMID 7503474
H. Wakisaka et al.: Demyelination associated with HSV-1-induced facial paralysis. Exp. Neurol. (2002) 178(1): S. 68-79 PMID 12460609
Eine Übersicht der HSV-Ösophagitiden in: K. Becker, H. J. Lübke, F. Borchard, D. Häussinger: Entzündliche Speiseröhrenerkrankungen durch Herpes-simplex-Virusinfektionen - Übersicht und Bericht über 15 eigene Fälle. Z. Gastroenterol. (1996) 34(5): S. 286-295 PMID 8686361
J. Ramanathan et al.: Herpes simplex virus esophagitis in the immunocompetent host: an overview. Am. J. Gastroenterol. (2000) 95(9): S. 2171–2176 PMID 11007213
Übersicht der diagnostischen Problematik in: Th. Mertens, O. Haller, H.-D. Klenk (Hg.): Diagnostik und Therapie von Viruskrankheiten - Leitlinien der Gesellschaft für Virologie. 2. Aufl. München 2004 ISBN 3-437-21971-5 S. 126-130
G. Biancofiore et al.: Liver transplantation due to Herpes Simplex virus-related sepsis causing massive hepatic necrosis after thoracoscopic thymectomy. Minerva Anestesiol. (2007) 73(5): S. 319-322 PMID 17529922
N. J. Schmidt, B. Forghani, E. H. Lennette: Type specificity of complement-requiring and immunoglobulin M neutralizing antibody in initial herpes simplex virus infections of humans. Infect Immun. (1975) 12(4): S. 728-732 PMID 1193713 pdf
Dickerson FB, Boronow JJ, Stallings C, et al (March 2004). "Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder". Biol. Psychiatry 55 (6): 588–93. doi:10.1016/j.biopsych.2003.10.008. PMID 15013827.
Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA (January 1997). "Herpes simplex virus type 1 in brain and risk of Alzheimer's disease". Lancet 349 (9047): 241–4. doi:10.1016/S0140-6736(96)10149-5. PMID 9014911.
Gupta R, Warren T, Wald A (December 2007). "Genital herpes". Lancet 370 (9605): 2127–37. doi:10.1016/S0140-6736(07)61908-4. PMID 18156035. http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(07)61908-4.
Brown ZA, Selke S, Zeh J, et al (August 1997). "The acquisition of herpes simplex virus during pregnancy". N Engl J Med. 337 (8): 509–15. doi:10.1056/NEJM199708213370801. PMID 9262493. http://content.nejm.org/cgi/content/full/337/8/509.
Takasu T, Furuta Y, Sato KC, Fukuda S, Inuyama Y, Nagashima K (1992). "Detection of latent herpes simplex virus DNA and RNA in human geniculate ganglia by the polymerase chain reaction". Acta Otolaryngol. 112 (6): 1004–11. doi:10.3109/00016489209137502. PMID 1336296.
Sugita T, Murakami S, Yanagihara N, Fujiwara Y, Hirata Y, Kurata T (1995). "Facial nerve paralysis induced by herpes simplex virus in mice: an animal model of acute and transient facial paralysis". Ann. Otol. Rhinol. Laryngol. 104 (7): 574–81. PMID 7598372.
Lazarini PR, Vianna MF, Alcantara MP, Scalia RA, Caiaffa Filho HH (2006). "Herpes simplex virus in the saliva of peripheral Bell's palsy patients" (in Portuguese). Rev Bras Otorrinolaringol (Engl Ed) 72 (1): 7–11. PMID 16917546.
Linder T, Bossart W, Bodmer D (2005). "Bell's palsy and Herpes simplex virus: fact or mystery?". Otol. Neurotol. 26 (1): 109–13. doi:10.1097/00129492-200501000-00020. PMID 15699730.
Kanerva M, Mannonen L, Piiparinen H, Peltomaa M, Vaheri A, Pitkäranta A (2007). "Search for Herpesviruses in cerebrospinal fluid of facial palsy patients by PCR". Acta Otolaryngol. 127 (7): 775–9. doi:10.1080/00016480601011444. PMID 17573575.
Stjernquist-Desatnik A, Skoog E, Aurelius E (2006). "Detection of herpes simplex and varicella-zoster viruses in patients with Bell's palsy by the polymerase chain reaction technique". Ann. Otol. Rhinol. Laryngol. 115 (4): 306–11. PMID 16676828.
Tiemstra JD, Khatkhate N (2007). "Bell's palsy: diagnosis and management". Am Fam Physician 76 (7): 997–1002. PMID 17956069.
Fleming, Thomas R. (2008). "Linear erosive Herpes Simplex Virus infection in immunocompromised patients: the “Knife-Cut Sign”". Clin Infect Dis 47: 1440–1441. doi:10.1086/591390.
Middleton PJ, Peteric M, Kozak M, Rewcastle NB, McLachlan DR. (1980). "Herpes simplex viral genome and senile and presenile dementias of Alzheimer and Pick.". Lancet 315: 1038. doi:10.1016/S0140-6736(80)91490-7.
Dobson CB, Itzhaki RF (1999). "Herpes simplex virus type 1 and Alzheimer's disease". Neurobiol. Aging 20 (4): 457–65. doi:10.1016/S0197-4580(99)00055-X. PMID 10604441. http://linkinghub.elsevier.com/retrieve/pii/S0197-4580(99)00055-X.
Pyles RB (November 2001). "The association of herpes simplex virus and Alzheimer's disease: a potential synthesis of genetic and environmental factors". Herpes 8 (3): 64–8. PMID 11867022. http://www.ihmf.com/journal/download/83pyles(64)vol864.pdf.
Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA (January 1997). "Herpes simplex virus type 1 in brain and risk of Alzheimer's disease". Lancet 349 (9047): 241–4. doi:10.1016/S0140-6736(96)10149-5. PMID 9014911.
Wozniak MA, Mee AP, Itzhaki RF (January 2009). "Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques". J Pathol. 217 (1): 131–8. doi:10.1002/path.2449. PMID 18973185. http://www3.interscience.wiley.com/journal/121411445/abstract.
Stumpf MP, Laidlaw Z, Jansen VA (2002). "Herpes viruses hedge their bets". Proc. Natl. Acad. Sci. U.S.A. 99 (23): 15234–7. doi:10.1073/pnas.232546899. PMID 12409612. http://www.pnas.org/content/99/23/15234.
Sainz B, Loutsch JM, Marquart ME, Hill JM (2001). "Stress-associated immunomodulation and herpes simplex virus infections". Med. Hypotheses 56 (3): 348–56. doi:10.1054/mehy.2000.1219. PMID 11359358.
My?liwska J, Trzonkowski P, Bryl E, Lukaszuk K, My?liwski A (2000). "Lower interleukin-2 and higher serum tumor necrosis factor-a levels are associated with perimenstrual, recurrent, facial Herpes simplex infection in young women". Eur. Cytokine Netw. 11 (3): 397–406. PMID 11022124.
Segal AL, Katcher AH, Brightman VJ, Miller MF (1974). "Recurrent herpes labialis, recurrent aphthous ulcers, and the menstrual cycle". J. Dent. Res. 53 (4): 797–803. PMID 4526372.
Chambers A, Perry M (2008). "Salivary mediated autoinoculation of herpes simplex virus on the face in the absence of "cold sores," after trauma". J. Oral Maxillofac. Surg. 66 (1): 136–8. doi:10.1016/j.joms.2006.07.019. PMID 18083428.
Perna JJ, Mannix ML, Rooney JF, Notkins AL, Straus SE (1987). "Reactivation of latent herpes simplex virus infection by ultraviolet light: a human model". J. Am. Acad. Dermatol. 17 (3): 473–8. doi:10.1016/S0190-9622(87)70232-1. PMID 2821086.
Rooney JF, Straus SE, Mannix ML, et al (1992). "UV light-induced reactivation of herpes simplex virus type 2 and prevention by acyclovir". J. Infect. Dis. 166 (3): 500–6. PMID 1323616.
Oakley C, Epstein JB, Sherlock CH (1997). "Reactivation of oral herpes simplex virus: implications for clinical management of herpes simplex virus recurrence during radiotherapy". Oral Surg Oral Med Oral Pathol Oral Radiol Endod 84 (3): 272–8. doi:10.1016/S1079-2104(97)90342-5. PMID 9377190.
Ichihashi M, Nagai H, Matsunaga K (2004). "Sunlight is an important causative factor of recurrent herpes simplex". Cutis 74 (5 Suppl): 14–8. PMID 15603217.
Martinez V, Caumes E, Chosidow O (2008). "Treatment to prevent recurrent genital herpes". Curr Opin Infect Dis 21 (1): 42–48. doi:10.1097/QCO.0b013e3282f3d9d3 (inactive 2008-06-25). PMID 18192785.
"AHMF: Preventing Sexual Transmission of Genital herpes". http://www.ahmf.com.au/health_professionals/guidelines/preventing_gh_transmission.htm. Retrieved on 2008-02-24.
Neinstein LS, Goldenring J, Carpenter S (July 1984). "Nonsexual transmission of sexually transmitted diseases: an infrequent occurrence". Pediatrics 74 (1): 67–76. PMID 6610855. http://pediatrics.aappublications.org/cgi/reprint/74/1/67.
Leone P (2005). "Reducing the risk of transmitting genital herpes: advances in understanding and therapy". Curr Med Res Opin 21 (10): 1577–82. doi:10.1185/030079905X61901. PMID 16238897.
Kim H, Meier A, Huang M, Kuntz S, Selke S, Celum C, Corey L, Wald A (2006). "Oral herpes simplex virus type 2 reactivation in HIV-positive and -negative men.". J Infect Dis 194 (4): 420–7. doi:10.1086/505879. PMID 16845624.
Mertz, G.J. (1993). "Epidemiology of genital herpes infections.". Infect Dis Clin North Am 7 (4): 825–39. PMID 8106731.
Wald A, Langenberg AG, Link K, Izu AE, Ashley R, Warren T, Tyring S, Douglas JM Jr, Corey L. (2001). "Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women". JAMA 285 (24): 3100–3106. doi:10.1001/jama.285.24.3100. PMID 11427138. http://jama.ama-assn.org/cgi/content/full/285/24/3100.
Casper C, Wald A. (2002). "Condom use and the prevention of genital herpes acquisition," (PDF). Herpes 9 (1): 10–14. PMID 11916494. http://www.ihmf.org/journal/download/91casper(10)vol910.pdf.
de Visser RO, Smith AM, Rissel CE, Richters J, Grulich AE. (2003). "Sex in Australia: safer sex and condom use among a representative sample of adults". Aust. N. Z. J. Public Health. 27 (2): 223–229. doi:10.1111/j.1467-842X.2003.tb00812.x. PMID 14696715.
Seppa, Nathan (2005-01-05). "One-Two Punch: Vaccine fights herpes with antibodies, T cells" (in English). Science News. pp. 5. http://www.sciencenews.org/articles/20050101/fob6.asp. Retrieved on 2007-03-29.
Carla K. Johnson (August 23, 2006). "Percentage of people with herpes drops". Associated Press. http://www.newsobserver.com/150/story/477928.html.
Kulhanjian JA, Soroush V, Au DS, et al (02 April 1992). "Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy". N. Engl. J. Med. 326 (14): 916–20. PMID 1311799. http://content.nejm.org/cgi/content/abstract/326/14/916.
Corey L, Wald A, Patel R, et al (January 2004). "Once-daily valacyclovir to reduce the risk of transmission of genital herpes". N Engl J Med. 350 (1): 11–20. doi:10.1056/NEJMoa035144. PMID 14702423. http://content.nejm.org/cgi/reprint/350/1/11.pdf.
Wald A, Langenberg AG, Krantz E, et al (November 2005). "The relationship between condom use and herpes simplex virus acquisition". Ann Intern Med. 143 (10): 707–13. PMID 16287791. http://www.annals.org/cgi/reprint/143/10/707.
Whitley RJ, Kimberlin DW, Roizman B (1998). "Herpes simplex viruses". Clin Infect Dis 26 (3): 541–53. doi:10.1086/514600. PMID 9524821. http://www.journals.uchicago.edu/doi/pdf/10.1086/514600.
Brown ZA, Benedetti J, Ashley R, et al (May 1991). "Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor". N. Engl. J. Med. 324 (18): 1247–52. PMID 1849612.
Koelle DM, Corey L (2008). "Herpes Simplex: Insights on Pathogenesis and Possible Vaccines". Annu Rev Med 59: 381–395. doi:10.1146/annurev.med.59.061606.095540. PMID 18186706.
Fatahzadeh M, Schwartz RA (2007). "Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management". J. Am. Acad. Dermatol. 57 (5): 737–63; quiz 764–6. doi:10.1016/j.jaad.2007.06.027. PMID 17939933.
Handsfield HH (2000). "Public Health Strategies to Prevent Genital Herpes: Where Do We Stand?". Curr Infect Dis Rep 2 (1): 25–30. doi:10.1007/s11908-000-0084-y. PMID 11095834.
Smith JS, Robinson NJ (2002). "Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review". J. Infect. Dis. 186 Suppl 1: S3–28. doi:10.1086/343739. PMID 12353183. http://www.journals.uchicago.edu/doi/full/10.1086/343739.
Patnaik P, Herrero R, Morrow RA, et al (2007). "Type-specific seroprevalence of herpes simplex virus type 2 and associated risk factors in middle-aged women from 6 countries: the IARC multicentric study". Sex Transm Dis 34 (12): 1019–24. PMID 18080353. http://www.stdjournal.com/pt/re/std/abstract.00007435-200712000-00016.htm.
Shin HS, Park JJ, Chu C, et al (2007). "Herpes simplex virus type 2 seroprevalence in Korea: rapid increase of HSV-2 seroprevalence in the 30s in the southern part". J. Korean Med. Sci. 22 (6): 957–62. doi:10.3346/jkms.2007.22.6.957. PMID 18162706.
Pebody RG, Andrews N, Brown D, et al (2004). "The seroepidemiology of herpes simplex virus type 1 and 2 in Europe". Sex Transm Infect 80 (3): 185–91. doi:10.1136/sti.2003.005850. PMID 15170000. http://sti.bmj.com/cgi/content/abstract/80/3/185.
Mertz GJ, Rosenthal SL, Stanberry LR (October 2003). "Is herpes simplex virus type 1 (HSV-1) now more common than HSV-2 in first episodes of genital herpes?". Sex Transm Dis 30 (10): 801–2. doi:10.1097/01.OLQ.0000093080.55201.D1. PMID 14520182. http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0148-5717&volume=30&issue=10&spage=801.
Roberts CM, Pfister JR, Spear SJ (2003). "Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students" (PDF). Sex Transm Dis 30 (10): 797–800. doi:10.1097/01.OLQ.0000092387.58746.C7. PMID 14520181. http://www.stdjournal.com/pt/re/std/pdfhandler.00007435-200310000-00012.pdf.
Malkin JE (2004). "Epidemiology of genital herpes simplex virus infection in developed countries" (PDF). Herpes 11 Suppl 1: 2A–23A. PMID 15115626. http://www.ihmf.org/journal/download/11Malkin(2A)sup12A.pdf.
"Herpes simplex" (in English) (HTML). University of Maryland Medical Center. http://www.umm.edu/patiented/articles/who_gets_herpes_simplex_virus_000052_4.htm. Retrieved on 2007-09-03.
"LEARN ABOUT HERPES > Fast Facts" (in English) (HTML). ASHA Herpes Resource Center. http://www.ashastd.org/herpes/herpes_learn.cfm. Retrieved on 2007-09-03.
"STD Facts - Genital Herpes" (in English) (HTML). Centers for Disease Control and Prevention. http://www.cdc.gov/std/Herpes/STDFact-Herpes.htm. Retrieved on 2007-09-03.
"Herpes" (in English) (HTML). Stanford University Sexual Health Peer Resource Center. http://www.stanford.edu/group/SHPRC/ch4_her.html. Retrieved on 2007-09-03.
a b Howard M, Sellors JW, Jang D, et al (January 2003). "Regional distribution of antibodies to herpes simplex virus type 1 (HSV-1) and HSV-2 in men and women in Ontario, Canada". J Clin Microbiol. 41 (1): 84–9. doi:10.1128/JCM.41.1.84-89.2003. PMID 12517830. PMC: 149555. http://jcm.asm.org/cgi/pmidlookup?view=long&pmid=12517830.
Patrick DM, Dawar M, Cook DA, Krajden M, Ng HC, Rekart ML (July 2001). "Antenatal seroprevalence of herpes simplex virus type 2 (HSV-2) in Canadian women: HSV-2 prevalence increases throughout the reproductive years". Sex Transm Dis 28 (7): 424–8. doi:10.1097/00007435-200107000-00011. PMID 11460028. http://www.stdjournal.com/pt/re/std/fulltext.00007435-200107000-00011.htm.
Singh AE, Romanowski B, Wong T, et al (February 2005). "Herpes simplex virus seroprevalence and risk factors in 2 Canadian sexually transmitted disease clinics". Sex Transm Dis 32 (2): 95–100. doi:10.1097/01.olq.0000151415.78210.85. PMID 15668615. http://www.stdjournal.com/pt/re/std/fulltext.00007435-200502000-00006.htm.
Forward KR, Lee SH (March 2003). "Predominance of herpes simplex virus type 1 from patients with genital herpes in Nova Scotia". Can J Infect Dis 14 (2): 94–6. PMID 18159431.
Weiss H (2004). "Epidemiology of herpes simplex virus type 2 infection in the developing world". Herpes 11 Suppl 1: 24A–35A. PMID 15115627.
Loutfy SA, Alam El-Din HM, Ibrahim MF, Hafez MM (2006). "Seroprevalence of herpes simplex virus types 1 and 2, Epstein-Barr virus, and cytomegalovirus in children with acute lymphoblastic leukemia in Egypt Kundi". Saudi Med J 27 (8): 1139–45. PMID 16883441.
Meguenni S, Djenaoui T, Bendib A, et al (1989). "Herpes simplex virus infections in Algiers" (in French). Arch Inst Pasteur Alger 57: 61–72. PMID 2562258.
Smith JS, Herrero R, Muå˜oz N, et al (2001). "Prevalence and risk factors for herpes simplex virus type 2 infection among middle-age women in Brazil and the Philippines". Sex Transm Dis 28 (4): 187–94. doi:10.1097/00007435-200104000-00001. PMID 11318248. http://www.stdjournal.com/pt/re/std/fulltext.00007435-200104000-00001.htm.
Kaur R, Gupta N, Baveja UK (2005). "Seroprevalence of HSV1 and HSV2 infections in family planning clinic attenders". J Commun Dis 37 (4): 307–9. PMID 17278662.
Dolar N, Serdaroglu S, Yilmaz G, Ergin S (2006). "Seroprevalence of herpes simplex virus type 1 and type 2 in Turkey". J Eur Acad Dermatol Venereol 20 (10): 1232–6. doi:10.1111/j.1468-3083.2006.01766.x. PMID 17062037.
Abuharfeil N, Meqdam MM (2000). "Seroepidemiologic study of herpes simplex virus type 2 and cytomegalovirus among young adults in northern Jordan". New Microbiol. 23 (3): 235–9. PMID 10939038.
Davidovici BB, Grotto I, Balicer RD, Robinson NJ, Cohen D (November 2006). "Decline in the prevalence of antibodies to herpes simplex virus types 1 and 2 among Israeli young adults between 1984 and 2002" (PDF). Sex Transm Dis 33 (11): 641–5. doi:10.1097/01.olq.0000216068.01028.38. PMID 16614586. http://www.stdjournal.com/pt/re/std/pdfhandler.00007435-200611000-00001.pdf.
Davidovici BB, Green M, Marouni MJ, Bassal R, Pimenta JM, Cohen D (2006). "Seroprevalence of herpes simplex virus 1 and 2 and correlates of infection in Israel". J. Infect. 52 (5): 367–73. doi:10.1016/j.jinf.2005.08.005. PMID 16213591.
Dan M, Sadan O., Glezerman M, Raveh D, Samra Z (2003). "Prevalence and risk factors for herpes simplex virus type 2 infection among pregnant women in Israel" (PDF). Sex Transm Dis 30(11): 835–8. PMID 14603091. http://www.stdjournal.com/pt/re/std/pdfhandler.00007435-200311000-00007.pdf.
Feldman PA, Steinberg J, Madeb R, et al (September 2003). "Herpes simplex virus type 2 seropositivity in a sexually transmitted disease clinic in Israel" (PDF). Isr. Med. Assoc. J. 5 (9): 626–8. PMID 14509150. http://www.ima.org.il/imaj/ar03sep-5.pdf.
Samra Z, Scherf E, Dan M (2003). "Herpes simplex virus type 1 is the prevailing cause of genital herpes in the Tel Aviv area, Israel". Sex Transm Dis 30 (10): 794–6. doi:10.1097/01.OLQ.0000079517.04451.79. PMID 14520180. http://www.stdjournal.com/pt/re/std/fulltext.00007435-200310000-00011.htm.
Ibrahim AI, Kouwatli KM, Obeid MT (2000). "Frequency of herpes simplex virus in Syria based on type-specific serological assay". Saudi Med J 21 (4): 355–60. PMID 11533818.
Cunningham AL, Taylor R, Taylor J, Marks C, Shaw J, Mindel A (2006). "Prevalence of infection with herpes simplex virus types 1 and 2 in Australia: a nationwide population based survey". Sex Transm Infect 82 (2): 164–8. doi:10.1136/sti.2005.016899. PMID 16581748. http://sti.bmj.com/cgi/content/abstract/82/2/164.
Haddow LJ, Dave B, Mindel A, et al (2006). "Increase in rates of herpes simplex virus type 1 as a cause of anogenital herpes in western Sydney, Australia, between 1979 and 2003". Sex Transm Infect 82 (3): 255–9. doi:10.1136/sti.2005.018176. PMID 16731681. http://sti.bmj.com/cgi/content/abstract/82/3/255.
Lyttle PH (1994). "Surveillance report: disease trends at New Zealand sexually transmitted disease clinics 1977-1993". Genitourin Med 70 (5): 329–35. PMID 8001945.
"Local anesthetic creams". BMJ 297 (6661): 1468. 1988. PMID 3147021.
Kaminester LH, Pariser RJ, Pariser DM, et al (1999). "A double-blind, placebo-controlled study of topical tetracaine in the treatment of herpes labialis". J. Am. Acad. Dermatol. 41 (6): 996–1001. doi:10.1016/S0190-9622(99)70260-4. PMID 10570387.
Chow AW, Roland A, Fiala M, et al (March 1973). "Cytosine arabinoside therapy for herpes simplex encephalitis--clinical experience with six patients". Antimicrob. Agents Chemother. 3 (3): 412–7. PMID 4790599. PMC: 444424. http://aac.asm.org/cgi/pmidlookup?view=long&pmid=4790599.
Kaufman HE, Howard GM (August 1962). "Therapy of experimental herpes simplex keratitis". Invest Ophthalmol 1: 561–4. PMID 14454441. http://www.iovs.org/cgi/pmidlookup?view=long&pmid=14454441.
Ch'ien LT, Whitley RJ, Alford CA, Galasso GJ (June 1976). "Adenine arabinoside for therapy of herpes zoster in immunosuppressed patients: preliminary results of a collaborative study". J. Infect. Dis. 133 Suppl: A184–91. PMID 180198.
McKelvey EM, Kwaan HC (November 1969). "Cytosine arabinoside therapy for disseminated herpes zoster in a patient with IgG pyroglobulinemia". Blood 34 (5): 706–11. PMID 5352659. http://www.bloodjournal.org/cgi/pmidlookup?view=long&pmid=5352659.
Fiala M, Chow A, Guze LB (April 1972). "Susceptibility of herpesviruses to cytosine arabinoside: standardization of susceptibility test procedure and relative resistance of herpes simplex type 2 strains". Antimicrob. Agents Chemother. 1 (4): 354–7. PMID 4364937. PMC: 444221. http://aac.asm.org/cgi/pmidlookup?view=long&pmid=4364937.
Allen LB, Hintz OJ, Wolf SM, et al (June 1976). "Effect of 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate on genital lesions and encephalitis induced by Herpesvirus hominis type 2 in female mice". J. Infect. Dis. 133 Suppl: A178–83. PMID 6598.
Juel-Jensen BE (March 1970). "Varicella and cytosine arabinoside". Lancet 1 (7646): 572. doi:10.1016/S0140-6736(70)90815-9. PMID 4190397.
Nahmias AJ, Kibrick S (May 1964). "Inhibitory effect of heparin on herpes simplex virus". J. Bacteriol. 87 (5): 1060–6. PMID 4289440. PMC: 277146. http://jb.asm.org/cgi/pmidlookup?view=long&pmid=4289440.
Allen LB, Sidwell RW (September 1972). "Target-organ treatment of neurotropic virus diseases: efficacy as a chemotherapy tool and comparison of activity of adenine arabinoside, cytosine arabinoside, idoxuridine, and trifluorothymidine". Antimicrob. Agents Chemother. 2 (3): 229–33. PMID 4790562. PMC: 444296. http://aac.asm.org/cgi/pmidlookup?view=long&pmid=4790562.
Allen LB, Wolf SM, Hintz CJ, Huffman JH, Sidwell RW (March 1977). "Effect of ribavirin on Type 2 Herpesvirus hominis (HVH/2) in vitro and in vivo". Ann. N. Y. Acad. Sci. 284: 247–53. doi:10.1111/j.1749-6632.1977.tb21957.x. PMID 212976.
Allen LB, Cochran KW (November 1972). "Target-organ treatment of neurotropic virus disease with interferon inducers". Infect. Immun. 6 (5): 819–23. PMID 4404669. PMC: 422616. http://iai.asm.org/cgi/pmidlookup?view=long&pmid=4404669.
Sidwell RW, Huffman JH, Khare GP, Allen LB, Witkowski JT, Robins RK (August 1972). "Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide". Science (journal) 177 (50): 705–6. PMID 4340949. http://www.sciencemag.org/cgi/pmidlookup?view=long&pmid=4340949.
Babiuk LA, Meldrum B, Gupta VS, Rouse BT (December 1975). "Comparison of the antiviral effects of 5-methoxymethyl-deoxyuridine with 5-iododeoxyuridine, cytosine arabinoside, and adenine arabinoside". Antimicrob. Agents Chemother. 8 (6): 643–50. PMID 1239978. PMC: 429441. http://aac.asm.org/cgi/pmidlookup?view=long&pmid=1239978.
O'Meara A, Deasy PF, Hillary IB, Bridgen WD (December 1979). "Acyclovir for treatment of mucocutaneous herpes infection in a child with leukaemia". Lancet 2 (8153): 1196. doi:10.1016/S0140-6736(79)92428-0. PMID 91931.
Whitley R, Arvin A, Prober C, et al (February 1991). "A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group". N. Engl. J. Med. 324 (7): 444–9. PMID 1988829. http://content.nejm.org/cgi/content/abstract/324/7/444.
Kimberlin DW, Lin CY, Jacobs RF, et al (August 2001). "Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections". Pediatrics 108 (2): 230–8. doi:10.1542/peds.108.2.230. PMID 11483782. http://pediatrics.aappublications.org/cgi/pmidlookup?view=long&pmid=11483782.
De Clercq E, Field HJ (2006). "Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapy". Br. J. Pharmacol. 147 (1): 1–11. doi:10.1038/sj.bjp.0706446. PMID 16284630.
Leung DT, Sacks SL. (2003). "Current treatment options to prevent perinatal transmission of herpes simplex virus". Expert Opin. Pharmacother. 4 (10): 1809–1819. doi:10.1517/14656566.4.10.1809. PMID 14521490.
The effects of antiviral therapy on the distribution of herpes simplex virus type 1 to ganglionic neurons and its consequences during, immediately following and several months after treatment"[1]"
Famciclovir and Valaciclovir Differ in the Prevention of Herpes Simplex Virus Type 1 Latency in Mice: a Quantitative Study"[2]"
Persistence of Infectious Herpes Simplex Virus Type 2 in the Nervous System in Mice after Antiviral Chemotherapy"[3]"
Observation May Indicate A Possible Clinical Effect On Latency"[4]"
Thackray AM, Field HJ. (1996). "Differential effects of famciclovir and valaciclovir on the pathogenesis of herpes simplex virus in a murine infection model including reactivation from latency". J. Infect. Dis. 173 (2): 291–299. PMID 8568288.
Worrall G (06 Jul 1996). "Evidence for efficacy of topical acyclovir in recurrent herpes labialis is weak". BMJ 313 (7048): 46. PMID 8664786. http://www.bmj.com/cgi/content/full/313/7048/46/a.
Spruance SL, Rea TL, Thoming C, Tucker R, Saltzman R, Boon R (1997). "Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group". JAMA 277 (17): 1374–9. doi:10.1001/jama.277.17.1374. PMID 9134943. http://jama.ama-assn.org/cgi/content/abstract/277/17/1374.
"Drug Name: ABREVA (docosanol) - approval". centerwatch.com. July 2000. http://www.centerwatch.com/patient/drugs/dru627.html. Retrieved on 2007-10-17.
"California Court Upholds Settlement Of Class Action Over Cold Sore Medicationl". BNA Inc.. July 2000. http://subscript.bna.com/SAMPLES/plp.nsf/85256269004a991e8525611300214487/29d5bb623a50fd25852572ad0074f772?OpenDocument. Retrieved on 2007-10-17.
Bishop, C.D. (1995). "Anti-viral Activity of the Essential Oil of Melaleuca alternifolia". Journal of Essential Oil Research: 641–644.
Kapinska-Mrowiecka M, Toruwski G (1996). "Efficacy of cimetidine in treatment of herpes zoster in the first 5 days from the moment of disease manifestation.". Pol Tyg Lek. 51 (23-26): 338–339. PMID 9273526.
Hayne ST, Mercer JB (1983). "Herpes zoster:treatment with cemetidine.". Can Med Assoc J 129 (12): 1284–1285. PMID 6652595.
Komlos L, Notmann J, Arieli J, et.al. (1994). "In vitro cell-mediated immune reactions in herpes zoster patients treated with cimetidine.". Asian Pac J Allelrgy Immunol 12 (1): 51–58. PMID 7872992.
De Bony F, Tod M, Bidault R, On NT, Posner J, Rolan P. (2002). "Multiple interactions of cimetidine and probenecid with valaciclovir and its metabolite acyclovir". Antimicrob. Agents Chemother. 46 (2): 458–463. doi:10.1128/AAC.46.2.458-463.2002. PMID 11796358.
Karadi I, Karpati S, Romics L. (1998). "Aspirin in the management of recurrent herpes simplex virus infection". Ann. Intern. Med. 128 (8): 696–697. PMID 9537952.
Gebhardt BM, Varnell ED, Kaufman HE. (2004). "Acetylsalicylic acid reduces viral shedding induced by thermal stress". Curr. Eye Res. 29 (2-3): 119–125. doi:10.1080/02713680490504588. PMID 15512958.
"Herpevac Trial for Women". http://www.niaid.nih.gov/dmid/stds/herpevac/. Retrieved on 2008-02-25.
"Molecular Therapy - Abstract of article: 801. RNA Gene Therapy Targeting Herpes Simplex Virus". http://www.nature.com/mt/journal/v13/n1s/abs/mt2006942a.html.
Perfect MM, Bourne N, Ebel C, Rosenthal SL (2005). "Use of complementary and alternative medicine for the treatment of genital herpes". Herpes 12 (2): 38–41. PMID 16209859.
McCune MA, Perry HO, Muller SA, O'Fallon WM. (2005). "Treatment of recurrent herpes simplex infections with L-lysine monohydrochloride". Cutis. 34 (4): 366–373. PMID 6435961.
Griffith RS, Walsh DE, Myrmel KH, Thompson RW, Behforooz A. (1987). "Success of L-lysine therapy in frequently recurrent herpes simplex infection. Treatment and prophylaxis". Dermatologica. 175 (4): 183–190. PMID 3115841.
Griffith RS, Norins AL, Kagan C. (1978). "A multicentered study of lysine therapy in Herpes simplex infection". Dermatologica. 156 (5): 257–267. PMID 640102.
Vogler BK and Ernst E.. "Aloe vera: a systematic review of its clinical effectiveness.". British Journal of General Practice 49: 823–828. http://www.jr2.ox.ac.uk/bandolier/booth/alternat/AT125.html.
Allahverdiyev A, Duran N, Ozguven M, Koltas S. (2004). "Antiviral activity of the volatile oils of Melissa officinalis L. against Herpes simplex virus type-2.". Phytomedicine. 11 (7-8): 657–661. doi:10.1016/j.phymed.2003.07.014. PMID 15636181.
Koytchev R, Alken RG, Dundarov S (1999). "Balm mint extract (Lo-701) for topical treatment of recurring herpes labialis". Phytomedicine 6 (4): 225–30. PMID 10589440.
Zacharopoulos VR, Phillips DM. (1997). "Vaginal formulations of carrageenan protect mice from herpes simplex virus infection". Clin. Diagn. Lab. Immunol. 4 (4): 465–468. PMID 9220165.
Carlucci MJ, Scolaro LA, Damonte EB. (1999). "Inhibitory action of natural carrageenans on Herpes simplex virus infection of mouse astrocytes". Chemotherapy 45 (6): 429–436. doi:10.1159/000007236. PMID 10567773.
Binns SE, Hudson J, Merali S, Arnason JT (2002). "Antiviral activity of characterized extracts from echinacea spp. (Heliantheae: Asteraceae) against herpes simplex virus (HSV-I)". Planta Med. 68 (9): 780–3. doi:10.1055/s-2002-34397. PMID 12357386.
Vonau B, Chard S, Mandalia S, Wilkinson D, Barton SE (2001). "Does the extract of the plant Echinacea purpurea influence the clinical course of recurrent genital herpes?". Int J STD AIDS 12 (3): 154–8. doi:10.1258/0956462011916947. PMID 11231867.
Docherty JJ, Fu MM, Stiffler BS, Limperos RJ, Pokabla CM, DeLucia AL. (1999). "Resveratrol inhibition of herpes simplex virus replication". Antiviral Res. 43 (3): 145–155. doi:10.1016/S0166-3542(99)00042-X. PMID 10551373.
Docherty JJ, Smith JS, Fu MM, Stoner T, Booth T. (2004). "Effect of topically applied resveratrol on cutaneous herpes simplex virus infections in hairless mice". Antiviral Res. 61 (1): 19–26. doi:10.1016/j.antiviral.2003.07.001. PMID 14670590.
Weber ND, Andersen DO, North JA, Murray BK, Lawson LD, Hughes BG (1992). "In vitro virucidal effects of Allium sativum (garlic) extract and compounds". Planta Med. 58 (5): 417–23. doi:10.1055/s-2006-961504. PMID 1470664.
Chiu LC, Zhub W, Oo VE (2004). "A polysaccharide fraction from medicinal herb Prunella vulgaris downregulates the expression of herpes simplex virus antigen in Vero cells". Journal of Ethnopharmacology 93 (1): 63–68. doi:10.1016/j.jep.2004.03.024.
Andersen JH, Jenssen H, Gutteberg TJ. (2003). "Lactoferrin and lactoferricin inhibit Herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir". Antiviral Res. 58 (3): 209–215. doi:10.1016/S0166-3542(02)00214-0. PMID 12767468.
Gaby AR (2006). "Natural remedies for Herpes simplex". Altern Med Rev 11 (2): 93–101. PMID 16813459.
Yazici AC, Baz K, Ikizoglu G (2006). "Recurrent herpes labialis during isotretinoin therapy: is there a role for photosensitivity?". J Eur Acad Dermatol Venereol 20 (1): 93–5.
|
